Audited information

Registered shares each with a par value of CHF 3.70 (2015: CHF 3.70)

 

Number of shares 2016

 

Par value 2016 in CHF m

 

Number of shares 2015

 

Par value 2015 in CHF m

Share capital as per 1 January

 

331 939 199

 

1 228

 

331 939 199

 

1 228

Share capital at 31 December

 

331 939 199

 

1 228

 

331 939 199

 

1 228

 

 

 

 

 

 

 

 

 

Treasury shares

 

–7 887 728

 

–29

 

–9 195 810

 

–34

Outstanding share capital at 31 December

 

324 051 471

 

1 199

 

322 743 389

 

1 194

Treasury shares (number of shares)

 

2016

 

2015

Holdings as per 1 January

 

9 195 810

 

12 087 920

Shares purchased at market value

 

819 813

 

1 016 761

Shares sold to counterparty out of options (management options 2010)

 

 

–2 077 650

Shares sold at market value

 

–1 240 318

 

–1 016 741

Shares transferred to employees

 

–887 577

 

–814 480

Holdings at 31 December

 

7 887 728

 

9 195 810

All shares are duly authorized and fully paid in.

Dividends are paid out as and when declared equally on all shares, excluding treasury shares. The information concerning payments per share to the shareholders are disclosed in the notes to the financial statements of Clariant Ltd.

In accordance with article 5 of the company’s Articles of Incorporation, no limitations exist with regard to the registration of shares which are acquired in one’s own name and on one’s own account. Special rules exist for nominees.

In accordance with article 13 of the company’s Articles of Incorporation, each share has the right to one vote.

Significant shareholdings of 3% or more of total share capital

Based on the notifications received by Clariant and published by SIX Exchange Regulation, as at 31 December 2016 the following shareholders held more than 3% of voting rights in Clariant Ltd:

Shareholders

 

 

Voting rights

1

The following former shareholders of Süd-Chemie AG form a group:

 

Wilhelm, Dr. Winterstein, Germany
Dolf, Dr. Stockhausen, Switzerland
Axel, Dr. Schweighart, Germany
Rosemarie Schweighart, Germany
Dominique Kraus, Germany
Karl, Dr. Wamsler, Germany
Irene W. Banning, United States
Susanne Wamsler-Singer, Austria
Caroline A., Dr. Wamsler, United States
Amelie Ratjen, Germany
Christof Ratjen, Germany
Christopher Weithauer, Germany
Johanna Bechtle, Germany
Kaspar Bechtle, Germany
Luisa Redetzki, Germany
Karl T. Banning, United States
Schuyler H. Joerger, United States

Konstantin Alfred Winterstein, Germany
Max-Theodor, Dr. Schweighart, Germany
Peter, Dr. Schweighart, Germany
Moritz Ostenrieder, Germany
Christian Ratjen, Germany
Bettina Wamsler, Germany
Pauline Joerger, United States
Marianne Kunisch, Germany
Maximilian Ratjen, Germany
Julius Ratjen, Germany
Elisabeth Prinzessin zu Sayn-Wittgenstein, Germany
Georg A. Weithauer, Germany
Charlotte Bechtle, Germany
Clara Redetzki, Germany
Marie Redetzki, Germany
Sophia P. Joerger, United States

2

According to a disclosure notification published on 18 January 2013, a group consisting of Konstantin Winterstein, 80333 München, Germany and Elisabeth Prinzessin zu Sayn-Wittgenstein, 80333 München, Germany holds 3.73% partially through Blue Beteiligungsgesellschaft mbH, Grossdingharting (Germany) and partially through Maple Beteiligungsgesellschaft mbH, Grossdingharting (Germany). The 3.73% held by this group are included in the 13.89% mentioned under footnote 1, but build a separate sub-group.

Group of former shareholders of Süd-Chemie AG1

 

 

13.89%

Thereof (as a separate sub-group): Blue Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82064 Grossdingharting (Germany) and Maple Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82064 Grossdingharting (Germany)2

 

 

3.73%

APG Asset Management N.V., Amsterdam, Netherlands

 

 

5.01%

BlackRock Inc., New York

 

 

3.08%

Cymbria, Canada
EdgePoint Global Portfolio, Canada
EdgePoint Canadian Growth and Income Portfolio, Canada
EdgePoint Canadian Portfolio, Canada
EdgePoint Global Growth and Income Portfolio, Canada
St. James Place Global Equity Unit Trust, UK

 

 

3.06%

Citadel Multi-Strategy Equities Sàrl
Citadel Global Equities Fund Sàrl
Citadel Securities (Europe) Limited

 

 

3.02%

Norges Bank (the Central Bank of Norway)

 

 

3.003%

UBS Funds Management (Switzerland) AG

 

 

3.001%

Disclosure notifications during the financial year 2016 reported to the Stock Exchange Disclosure Office pursuant to Art. 120 of the Financial Markets Infrastructure Act (FMIA) as well as further information in relation to disclosure notifications can be found on the SIX Swiss Exchange reporting platform: www.six-exchange-regulation.com/en/home/publications/significant-shareholders.html

As of 31 December 2016, former shareholders of Süd-Chemie AG, who had exchanged their shares against Clariant shares in April 2011, held a total of 13.89% of the share capital of Clariant Ltd. These shareholders are related to each other for family or other reasons (especially the Wamsler, Winterstein, Schweighart and Stockhausen families).

In addition, at 31 December 2015, the following shareholders held a participation of 3% or more of the total share capital: Group of former shareholders of Süd-Chemie AG: 13.89% (thereof (as a separate sub-group): Blue Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82064 Grossdingharting (Germany) and Maple Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82064 Grossdingharting (Germany): 3.73%); APG Asset Management N.V., Amsterdam, Netherlands: 5.01%; Cymbria, (Canada): 3.06%, Black Rock Inc., New York: 3.05%.

At 31 December 2016, Clariant AG itself held 7 887 728 shares in treasury, corresponding to 2.38% of the share capital.

Distribution to shareholders

On 21 April 2016 the Annual General Meeting of Clariant Ltd approved a distribution from the confirmed capital contribution reserves of CHF 0.40 per share. This was paid out on 28 April 2016 reducing the capital contribution reserves by CHF 129 million.

Non-controlling interests

In December 2016 Clariant sold shares of Clariant Chemicals (India) Ltd in the stock market for an amount of CHF 29 million. As a result the percentage of non-controlling interests in this company increased from 35.8% to 49%. The transaction resulted in a gain of CHF 16 million, which was recognized in equity.

In October 2015 Clariant Chemicals (India) Ltd engaged in a share buyback. This resulted in the amount of CHF 21 million being paid out to minority shareholders and CHF 29 million to Group-internal parent companies. As a consequence the percentage of non-controlling interests in this company decreased from 36.6% to 35.8%.

At 31 December 2016, non-controlling interests reported are primarily made up of those of the three following companies. They amount to more than 65% of the minority shares reported:

Clariant Huajin (Panjin) Ltd, reported sales in the amount of CHF 28 million in the reporting period and total assets in the amount of CHF 35 million as per 31 December 2016. The non-controlling interests of 40% of the shares outstanding is held by Northern Huajin Chemical Industry Group Co. Ltd.

Clariant Chemicals (India) Ltd reported sales in the amount of CHF 140 million in the reporting period and CHF 135 million of total assets as per 31 December 2016. The non-controlling interests of 49% of the shares outstanding is traded on the Bombay Stock Exchange (BSE) in Mumbai.

Clariant Catalysts (Japan) K.K. reported sales in the amount of CHF 148 million in the reporting period and CHF 96 million of total assets as per 31 December 2016. The non-controlling interests of 38.6% of the shares outstanding are held by Nissan Chemicals Industries Ltd.

Catalyst

A substance that lowers the activation energy, thereby increasing the rate of a chemical reaction without being consumed by the reaction itself (Clariant Business Unit Catalysts). VIEW ENTIRE GLOSSARY

FURTHER READING